Coronavirus Pandemic Impact

Traders need to remember that the Coronavirus as a catalyst of the bear market, not the cause, notes Al Brooks.

When the Coronavirus pandemic struck in February, traders were confident of one thing: They knew it would drastically change the behavior of consumers.

Since consumer spending is responsible for 70% of GDP, companies would make less money or even lose money. The value of companies is based on earnings. If the total earnings of America’s companies were going to be less, the price of stocks had to fall.

No one knew how bad the unemployment and the reduced spending would be. But everyone knew the economy would be bad. It took a while for America to conclude that life will not get back to normal until there is a vaccine next year. I am a physician with some virology expertise, and I had been saying that from mid-February.

The stock market leads the economy

The stock market is actually a futures market. People buy stock based on what they think the price will be in the future. Therefore, the market typically goes down before there is a recession and up before a recession ends.

The market has rallied strongly over the past four weeks. This is because traders concluded that a 34% reduction in the stock market’s price was more than what was needed to account for the damage from the pandemic.

The market is now in search of a price that is appropriate. Traders concluded that the February high is too high and the March low is too low. Somewhere in the middle is just about right.

It will take many months to find the theoretical fair price. As traders become more confident of what the fair price is, the legs up and down will get smaller.

After many months of equilibrium, traders will become confident that there is no more significant risk of a second or third wave of infections and economic damage. Traders will begin to ignore the pandemic and then life will start to get back to normal, or at least a new normal. Once that happens, the bulls would then try to create a rally to a new high.

The vaccine will probably work

Traders want to know that a vaccine will work. Vaccines work for most viruses, but not all. HIV is an obvious example. It took decades to create a reasonably good treatment for people infected with HIV. A satisfactory treatment is one that helps the patient and greatly reduces the chance of spreading the virus to others.

For Covid-19, it would probably also take many years to develop a comparably effective treatment. A treatment without a vaccine would have the world living with the virus indefinitely and possibly forever. That dismal prospect would be a chronic weight on the economy.

Remdesivir might help

There was a report this week from my alma mater, the University of Chicago, concerning Gilead’s Remdesivir. They used it to treat 113 patients with severe disease and most were discharged within a week.

While it is good that the drug appears to reduce the death rate, it is not enough to make American life normal again. Being on one’s death bed and then surviving is better than not surviving. But whoever wants to be so sick that he is on a deathbed? That is not our normal life.

It is important to note that there are politics in everything, including medical research. I was a medical scientist decades ago and saw it for myself at many major medical centers. Also, there are statistical abnormalities that result in what appears to be a good result, but is actually just a coincidence. Doctors know this and therefore want to see similar results from several medical centers before being confident that a drug is truly helpful.

What traders want from a vaccine

Traders want a vaccine that will prevent infection in a large percentage of the population. For example, the flu vaccine only works in about 70% of people who get vaccinated. People want a more reliable vaccine than that because Covid-19 is a more serious illness. Traders also want the protection to be permanent or last at least several years.

Viruses mutate: If they mutate enough, the old vaccine is ineffective. I would not be surprised if a coronavirus vaccine gets incorporated into the annual flu shot.

Finally, traders want to be sure that a vaccine will not have horrible side effects. If it does, many will refuse to get vaccinated. The result will be lots of people choosing to risk getting sick and passing the infection to others. That would prolong the damage to the economy.

These uncertainties will be here for another year. That will probably keep the market sideways into 2021.

What if the pandemic is not the main problem?

I have mentioned since late 2017 that the E-mini S&P 500 was the most overbought in the 100-year history of the stock market. I said that it would probably take a decade for the fundamentals to catch up to the high price.

That is what happened after the buy climaxes in the 1960’s and the 1990’s. Each led to about a decade of sideways trading. There were 50% selloffs and 100% rallies, but the market was in a trading range. The market sometimes made new highs, but they led to a reversal back down instead of a bull trend.

The stock market has been in a trading range for more than two years. I suspect that it will probably continue in a range between 1800 and 3600 for the rest of the decade. I do think that there will be at least one more new high. It might even come next year. But the market will likely have a difficult time getting far above this year’s high for a long time.

What happens if the market rallies to 4,000 within a few years? That would indicate that the fundamentals had caught up to price. The odds of another bull trend at that point could be better than 50%. But, without that, there is a 60% chance that the two-year trading range will continue for at least several more years.

Trading Room
Traders can see the end of the day bar-by-bar price action report by signing up for free at BrooksPriceAction.com. I talk about the detailed E-mini price action real-time throughout the day in the BrooksPriceAction.com trading room. We offer a two-day free trial.